{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:50:35Z","timestamp":1790272235488,"version":"4.1.0"},"reference-count":24,"publisher":"Impact Journals, LLC","issue":"43","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,10,25]]},"DOI":"10.18632\/oncotarget.12226","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T21:55:05Z","timestamp":1474667705000},"page":"70845-70856","source":"Crossref","is-referenced-by-count":37,"title":["Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Katarzyna","family":"Baranowska","sequence":"first","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Misund","sequence":"additional","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian K.","family":"Starheim","sequence":"additional","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway"},{"name":"CEMIR-Center of Molecular Inflammation Research, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toril","family":"Holien","sequence":"additional","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Johansson","sequence":"additional","affiliation":[{"name":"CEMIR-Center of Molecular Inflammation Research, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway"},{"name":"Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Darvekar","sequence":"additional","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Buene","sequence":"additional","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Waage","sequence":"additional","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway"},{"name":"Department of Hematology, St. Olav's University Hospital, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir","family":"Bj\u00f8rk\u00f8y","sequence":"additional","affiliation":[{"name":"CEMIR-Center of Molecular Inflammation Research, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway"},{"name":"Department of Medical Laboratory Technology, Faculty of Technology, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Sundan","sequence":"additional","affiliation":[{"name":"Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway"},{"name":"CEMIR-Center of Molecular Inflammation Research, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,9,23]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1182\/blood-2012-04-403733","article-title":"Proteasome inhibitors in multiple myeloma: 10 years later","volume":"120","author":"Harousseau","year":"2012","journal-title":"Blood"},{"key":"2","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1158\/0008-5472.CAN-06-4086","article-title":"Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome","volume":"67","author":"Sun","year":"2007","journal-title":"Cancer Res"},{"key":"3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/jnci\/djr160","article-title":"Novel proteasome inhibitors to overcome bortezomib resistance","volume":"103","author":"Schimmer","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"4","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1182\/blood-2007-01-065888","article-title":"Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma","volume":"110","author":"Orlowski","year":"2007","journal-title":"Blood"},{"key":"5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/ni.2524","article-title":"Plasma cells require autophagy for sustainable immunoglobulin production","volume":"14","author":"Sitia","year":"2013","journal-title":"Nat Immunol"},{"key":"6","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1158\/0008-5472.CAN-06-2258","article-title":"Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition","volume":"67","author":"Voll","year":"2007","journal-title":"Cancer Res"},{"key":"7","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1158\/1535-7163.Mct-12-0782","article-title":"Endoplasmic Reticulum Stress and the Unfolded Protein Response: Targeting the Achilles Heel of Multiple Myeloma","volume":"12","author":"Samali","year":"2013","journal-title":"Molecular Cancer Therapeutics"},{"key":"8","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1158\/1078-0432.CCR-12-1881","article-title":"New strategies in the treatment of multiple myeloma","volume":"19","author":"Anderson","year":"2013","journal-title":"Clin Cancer Res"},{"key":"9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ceb.2009.11.002","article-title":"Autophagy: links with the proteasome","volume":"22","author":"Johansen","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"10","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.febslet.2009.12.047","article-title":"Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems","volume":"584","author":"Rubinsztein","year":"2010","journal-title":"FEBS Lett"},{"key":"11","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1152\/physrev.00030.2009","article-title":"Regulation of mammalian autophagy in physiology and pathophysiology","volume":"90","author":"Moreau","year":"2010","journal-title":"Physiol Rev"},{"key":"12","doi-asserted-by":"crossref","DOI":"10.1039\/9781849735346","article-title":"Autophagy modulation as a potential therapeutic target for diverse diseases","volume":"11","author":"Levine","year":"2012","journal-title":"Nature Reviews Drug Discovery"},{"key":"13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ejphar.2009.06.063","article-title":"Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies","volume":"625","author":"Lee","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"14","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.4161\/auto.29264","article-title":"Combined autophagy and proteasome inhibition: A phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed\/refractory myeloma","volume":"10","author":"Porter","year":"2014","journal-title":"Autophagy"},{"key":"15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1083\/jcb.200507002","article-title":"p62\/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death","volume":"171","author":"Johansen","year":"2005","journal-title":"J Cell Biol"},{"key":"16","doi-asserted-by":"publisher","first-page":"24131","DOI":"10.1074\/jbc.M702824200","article-title":"p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy","volume":"282","author":"Johansen","year":"2007","journal-title":"J Biol Chem"},{"key":"17","first-page":"5320","article-title":"Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications","volume":"53","author":"Lust","year":"1993","journal-title":"Cancer Res"},{"key":"18","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1177\/1087057113478168","article-title":"A Method for Measurement of Drug Sensitivity of Myeloma Cells Co-Cultured with Bone Marrow Stromal Cells","volume":"18","author":"Sundan","year":"2013","journal-title":"Journal of Biomolecular Screening"},{"key":"19","volume-title":"Cellular Degradation Machineries in Age-Related Loss of Muscle Mass (Sarcopenia)","author":"Nagata","year":"2012"},{"key":"20","doi-asserted-by":"publisher","first-page":"M111 014035","DOI":"10.1074\/mcp.M111.014035","article-title":"Identification of autophagosome-associated proteins and regulators by quantitative proteomic analysis and genetic screens","volume":"11","author":"Nielsen","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"21","doi-asserted-by":"publisher","first-page":"22576","DOI":"10.1074\/jbc.M110.118976","article-title":"p62\/SQSTM1 Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription","volume":"285","author":"Johansen","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ncb2021","article-title":"The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1","volume":"12","author":"Iemura","year":"2010","journal-title":"Nature Cell Biology"},{"key":"23","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1158\/1535-7163.MCT-08-1177","article-title":"Effect of autophagy on multiple myeloma cell viability","volume":"8","author":"Lichtenstein","year":"2009","journal-title":"Molecular Cancer Therapeutics"},{"key":"24","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.5775.5775","article-title":"A Phase II Trial of Chloroquine in Combination with Bortezomib and Cyclophosphamide in Patients with Relapsed and Refractory Multiple Myloma","author":"Montanari","year":"2014","journal-title":"Blood"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T14:26:11Z","timestamp":1589293571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,23]]},"references-count":24,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2016,10,25]]}},"alternative-id":["12226","27683126"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.12226","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,23]]}}}